China's SFDA Says Fewer Drug Approvals Last Year Reflect Crackdown
This article was originally published in PharmAsia News
Executive Summary
Chinese health authorities reported approval figures for the past year that reflect an increase in regulatory oversight over new drugs attempting to enter the market